RELATED CONTENT
NEWS
- US regulators question safety data for Forest/Almirall COPD drug
- Forest, Almirall COPD drug wins US FDA lung panel's backing
- Intermune's orphan Esbriet falls foul of Germany's benefit assessment
- YM BioSciences rises on PhI/II results showing promise for JAK1/JAK2 inhibitor for myelofibrosis
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

